Adherence to a Mediterranean diet and risk of incident cognitive impairment
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 20, 2012
- Accepted in final form January 22, 2013
- First Published April 29, 2013.
Author Disclosures
- Georgios Tsivgoulis, MD,
- Suzanne Judd, PhD,
- Abraham J. Letter, MS,
- Andrei V. Alexandrov, MD,
- George Howard, DrPH,
- Fadi Nahab, MD,
- Frederick W. Unverzagt, PhD,
- Claudia Moy, PhD,
- Virginia J. Howard, PhD,
- Brett Kissela, MD and
- Virginia G. Wadley, PhD
- Georgios Tsivgoulis, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Suzanne Judd, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Abraham J. Letter, MS,
NONE
NONE
NONE
NONE
NONE
NONE
WL Gore and Associates, Clinical Biostatistician since Jan 2012 working on clinical studies of aortic endoprostheses
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andrei V. Alexandrov, MD,
Commercial entity: Cerevast Therapeutics, Inc
NONE
NONE
Brain and Behavior, Editor-in-Chief, 2011 - present Stroke, Editorial Board member, 1998 - present International Journal of Stroke, Associate Editor 2006- 2011 Cerebrovascular Diseases, Editorial Board member, 2011- present
Therapeutic Methods and Apparatus for Use of Sonication to Enhance Perfusion of Tissue Inventors: Alexandrov AV, Aronowski J, Wojner AW US patent 6,733,450 (May 11, 2004) Assignee: Texas Systems, Board of Reagents
Alexandrov AV. Cerebrovascular Ultrasound in Stroke Prevention and Treatment. New York: Futura / Blackwell Publishing. 2003. ISBN 1- 4051-0381-7 Alexandrov AV. Cerebrovascular Ultrasound in Stroke Prevention and Treatment. Oxford: Blackwell Publishing (in Chinese) 2007. ISBN 7- 117-07389-6 Alexandrov AV. Cerebrovascular Ultrasound in Stroke Prevention and Treatment. (2nd Edition) Oxford: Wiley-Blackwell Publishers. 2011. 9781405195768.
NONE
Commercial entity: Cerevast Therapeutics, Inc.
NONE
NONE
Comprehensive Stroke Center, UAB Hospital 60% effort on clinical stroke service; monitoring endovascular procedures and evaluating success of recanalization with imaging. 2007-till present.
Commercial entity: Cerevast Therapeutics, Inc.
NINDS, Project 4 CLOTBUST-Hands Free of the SPOTRIAS: University of Texas Specialized Program in Translational Research in Acute Stroke
NONE
NONE
Commercial entity: Cerevast Therapeutics, Inc.
Therapeutic Methods and Apparatus for Use of Sonication to Enhance Perfusion of Tissue Inventors: Alexandrov AV, Aronowski J, Wojner AW US patent 6,733,450 (May 11, 2004) Assignee: Texas Systems, Board of Reagents Source of payment: Cerevast Therapeutics, Inc.
Therapeutic Methods and Apparatus for Use of Sonication to Enhance Perfusion of Tissue Inventors: Alexandrov AV, Aronowski J, Wojner AW US patent 6,733,450 (May 11, 2004) Assignee: Texas Systems, Board of Reagents Source of payment: Cerevast Therapeutics, Inc.
NONE
NONE
NONE
- George Howard, DrPH,
ARRIVE Study Executive Committee Board for Bayer Healthcare; served as a consultant in for an FDA application for Abbott Vascular; Advisory board for Boehringer Ingelheim, Brainsgate, Cerevast, CoAxia, LifeVest, MediciNova, Mitsubishi, and PhotoThera
NONE
NONE
Stroke Section Editor Stroke and Cerebrovascular Disease Editorial Board
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Amgen - Treatment of Early Agressive Rheumatoid Arthritis - TEAR
NINDS, PI, REasons for Geographic And Racial Differences in Stroke - REGARDS (NS41588) NINDS, co-PI of Coordinating Center, Carotid Revascularization Endarterectomy Stenting Trial - CREST (NS38384) NIAMS, co-PI, Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis - (AR02247) NICHD, co-PI, Vaginal Ultrasound Cerclage Trial HD39939 NINDS, co-I, Secondary Prevention of Small Subcortical Stroke - SPS3 (NS038529) NHLBI, co-I, SCCOR in Cardiac Dysfunction, (HL77100) NINDS, co-I, Psychosocial impact of stroke on family caregivers (NS34789)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Pfizer legal issues, consultant, 2012
- Fadi Nahab, MD,
NONE
NONE
National Stroke Association speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Frederick W. Unverzagt, PhD,
NONE
NONE
NONE
Neuropsychology, Editorial Board, 2007-present
NONE
NONE
NONE
UCB Pharma
NONE
NONE
NONE
Posit Science Inc.
R01 AG026096, PI, 2006-2011 U01 NR004508, PI, 20082011 R01 AG09956, CoI, 1991-2011 P30 AG10133, CoI, 1991-2011 U01 NS041588, CoI, 2007-2012 ITRAC, PI, 2008-2009 RSGPB04-089-01-PBP, ACS, CoI, 2004-2009
NONE
NONE
Eli Lilly
NONE
NONE
NONE
NONE
NONE
- Claudia Moy, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
currently a Federal government employee
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Virginia J. Howard, PhD,
Self - (1) Serve on DSMB for NIH-NIDA Immediate family member scientific advisory boards for: (1) NHLBI cohort study, (2) the ARRIVE Study (Bayer Healthcare) Spouse served on DSMBs for: (1) PhotoThera, (2) Medicinova, (3) Univ of London
NONE
NONE
NONE
NONE
NONE
NONE
Personal - NIH review committees Immediate family member consulting: NIH review committees
NONE
NONE
NONE
NONE
Self: 1) NIH-NINDS, NS41588, co-PI, 2001- present, (2) NIH-NINDS, NS38384, co-investigator, 1999-present, (3) NIH-NINDS NS061846, co- investigator, 2008-present, (4) NIH-NIA AG039588, PI, 2011-present (5) CDC, FY10OHDLZCO, 2009-present, co- investigator. Spouse: 1) NIH-NINDS, NS41588, co-PI, 2001- present, (2) NIH-NINDS, NS38384, co-investigator, 1999-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brett Kissela, MD and
(1) for Allergan with compensation (scientific advisor)
NONE
Allergan, travel costs and honoraria for speaking
NONE
NONE
NONE
NONE
NONE
NONE
Reata Pharmaceuticals--I will receive compensation to serve on the Event Adjudication Committee for the BEACON study, which they are sponsoring
NONE
NONE
NIH funding for multiple grants
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I have served as an expert witness in medicolegal cases related to stroke within the prior 2 years. In this capacity, I have performed chart reviews and been deposed on one occassion.
- Virginia G. Wadley, PhD
(1) Amgen, Inc. Scientific Advisory Board
NONE
Amgen, Inc., travel expenses and honorarium
Current Gerontology and Geriatrics Research, editoral board, 2010-present, no compensation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Genzyme Therapeutics, investigator-initiated grant, PI
(1)NIH, NO1 HC48047, Co-I, 1989-2013 (2)NIH, U01 NS51488, Co-I, 2007-2012 (3)NIH, R01 NS061846,Co-I, 2008-2013 (4)NIH, P30 AG022838,Co-I,2009-2014 (5)NIH, HHSN268200900047C, Co-I, 20092018 (6)NIH, R01 AG021958, Co-I, 20092014 (7)NIH, R01 AG039588, Co-I, 2011-2016 (8)Jefferson County [AL] Office of Senior Citizens Services, PI, 20062011 (9)NIH, R01 NS45789, Co-I. 2005-2011 (10)NIH, U01 AG14289, Co-I, 2008-2011 (11)NIH, R01 AG005739, Co-I, 20062011
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Second Department of Neurology, School of Medicine, Attikon Hospital, University of Athens, Greece; Comprehensive Stroke Center (G.T., A.V.A.), the Departments of Biostatistics (S.J., A.J.L., G.H.) and Epidemiology (V.J.H.), School of Public Health, and the Department of Medicine (V.G.W.), University of Alabama at Birmingham, Birmingham; International Clinical Research Center (G.T.), St. Anne's University Hospital Brno, Brno, Czech Republic; the Department of Neurology (F.N.), Emory University, Atlanta, GA; the Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis; National Institute of Neurological Disorders and Stroke (C.M.), National Institutes of Health, Bethesda, MD; and the Department of Neurology (B.K.), University of Cincinnati, Cincinnati, OH. Coinvestigators are listed on the Neurology® Web site at www.neurology.org.
- Correspondence to Dr. Tsivgoulis: tsivgoulisgiorg{at}yahoo.gr
Article usage
Cited By...
Letters: Rapid online correspondence
- ApoE alleles may explain some of the findings
- William B. Grant, Researcher, Sunlight, Nutrition and Health Research Centerwbgrant@infionline.net
Submitted May 07, 2013
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan